jemperli
glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.
beyfortus
astrazeneca ab - nirsevimab - odporne surowicy i immunoglobuliny, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
eptifibatide mylan 0,75 mg/ml roztwór do infuzji
mylan s.a.s. - eptifibatidum - roztwór do infuzji - 0,75 mg/ml
eptifibatide mylan 2 mg/ml roztwór do wstrzykiwań
mylan s.a.s. - eptifibatidum - roztwór do wstrzykiwań - 2 mg/ml
nebispes 5 mg tabletki
bausch health ireland ltd. - nebivololum - tabletki - 5 mg
nebicard 5 mg tabletki
biofarm sp. z o.o. - nebivololum - tabletki - 5 mg
nebivor 5 mg tabletki
orion corporation - nebivololum - tabletki - 5 mg
nedal 5 mg tabletki
zakłady farmaceutyczne polpharma s.a. - nebivololum - tabletki - 5 mg
nebivolek 5 mg tabletki
sandoz gmbh - nebivololi hydrochloridum - tabletki - 5 mg
ebivol 5 mg tabletki
actavis group ptc ehf. - nebivololi hydrochloridum - tabletki - 5 mg